1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, November 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, November 2016 (p7)

24/7 Customer Support

Talk to Veronica

+1 718 514 2762

181-210 of about 1500 reports

Purchase Reports From Reputable Market Research Publishers

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Therapy, Biotechnology, Pathology, Biopharmaceutical, Biological Therapy, Pharmaceutical
  • Countries : United States
Hypercholesterolemia - Pipeline Review, H2 2016

Hypercholesterolemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hypercholesterolemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypercholesterolemia – Pipeline Review, H2 2016, provides an ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections ...

  • Industries : Pathology, Healthcare, Therapy, Biopharmaceutical
  • Countries : United States
Gouty Arthritis (Gout) - Pipeline Review, H2 2016

Gouty Arthritis (Gout) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Gouty Arthritis (Gout) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis (Gout) – Pipeline Review, H2 2016, provides ...

  • Industries : Chronic Disease, Pathology, Therapy, Pharmaceutical
  • Countries : United States, World
Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis (Kala-Azar) – Pipeline Review, H2 2016, ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Psoriatic Arthritis - Pipeline Review, H2 2016

Psoriatic Arthritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Psoriatic Arthritis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Healthcare, Biopharmaceutical, Pharmaceutical
  • Countries : United States
Systemic Lupus Erythematosus - Pipeline Review, H2 2016

Systemic Lupus Erythematosus - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Systemic Lupus Erythematosus - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Ankylosing Spondylitis (Bekhterev%s Disease) - Pipeline Review, H2 2016

Ankylosing Spondylitis (Bekhterev%s Disease) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis – Pipeline Review, ...

  • Industries : Pathology, Biopharmaceutical, Healthcare, Biotechnology, Pharmaceutical
  • Countries : United States
Macular Edema - Pipeline Review, H2 2016

Macular Edema - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Macular Edema - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy, Pharmaceutical, Biopharmaceutical, Pathology
  • Countries : United States
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2016

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistant ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Tuberculosis - Pipeline Review, H2 2016

Tuberculosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Tuberculosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States, World
Thrombocytopenia - Pipeline Review, H2 2016

Thrombocytopenia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Thrombocytopenia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Malaria - Pipeline Review, H2 2016

Malaria - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Malaria - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria ...

  • Industries : Pathology, Healthcare, Therapy, Pharmaceutical
  • Countries : United States
Pemphigus Vulgaris - Pipeline Review, H2 2016

Pemphigus Vulgaris - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Pemphigus Vulgaris - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Diabetic Retinopathy - Pipeline Review, H2 2016

Diabetic Retinopathy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Diabetic Retinopathy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Retinopathy – Pipeline Review, H2 2016, provides an ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Renal Cell Carcinoma - Pipeline Review, H2 2016

Renal Cell Carcinoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Renal Cell Carcinoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an ...

  • Industries : Cancer, Pathology
  • Countries : United States
Muscular Dystrophy - Pipeline Review, H2 2016

Muscular Dystrophy - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Muscular Dystrophy - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Muscular Dystrophy – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
U.S. Biological Products (Except Diagnostic) Market. Analysis And Forecast to 2020

U.S. Biological Products (Except Diagnostic) Market. Analysis And Forecast to 2020

  • $ 2161
  • Industry report
  • December 2016
  • by IndexBox Marketing

The report provides an in-depth analysis of the U.S. biological products (except diagnostic) market. It presents the latest data of the market size and volume, domestic production, exports and imports, ...

  • Industries : Biopharmaceutical
  • Countries : United States
Prometheon Pharma, LLC - Product Pipeline Review - 2016

Prometheon Pharma, LLC - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • October 2016
  • by Global Markets Direct

Prometheon Pharma, LLC - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Prometheon Pharma, LLC - Product Pipeline Review - 2016’, provides an overview of the Prometheon Pharma, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biopharmaceutical, Chronic Disease
  • Countries : World, United States
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology

Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology

  • $ 1386
  • Industry report
  • December 2016
  • by La Merie Publishing

Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology This product consists of four reports in pdf format describing the competitive field of new molecular entities directed ...

  • Industries : Biological Therapy, Therapy, Biotechnology
  • Countries : United States
Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021

Americas Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2021

  • $ 1000
  • Industry report
  • December 2016
  • by Igate Research

The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology, Pharmaceutical
  • Countries : World, United States, North America, Mexico
Success Case Study: Fairlife Milk

Success Case Study: Fairlife Milk

  • $ 995
  • Industry report
  • December 2016
  • by Canadean Ltd

Summary The dairy industry faces several challenges due to consumers' concerns about several issues associated with milk: health problems (lactose intolerance, high calories) and environmental issues ...

  • Industries : Dairy Products
  • Countries : United States
CD22: a suitable antigen for targeted payload delivery by immunotherapeutics

CD22: a suitable antigen for targeted payload delivery by immunotherapeutics

  • $ 770
  • Industry report
  • November 2016
  • by La Merie Publishing

CD22: a suitable antigen for targeted payload delivery by immunotherapeutics This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Morphtek Cancer Drugs Clinical Pipeline Insight

Morphtek Cancer Drugs Clinical Pipeline Insight

  • $ 500
  • Industry report
  • November 2016
  • by PNS Pharma

“Morphtek - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Morphtek. This report highlights various clinical and non-clinical ...

  • Industries : Therapy, Biopharmaceutical
  • Countries : United States
Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

Oncology drug report - Adcetris - brentuximab vedotin - 2011-2015 analysis; 2016-2021 expectations

  • $ 500
  • Industry report
  • November 2016
  • by Cancer Research Analytics

“Adcetris: 2011-2015 analysis; 2016-2021 expectations” is a comprehensive report on the first and only approved drug of Seattle Genetics called Adcetris, which is also the first drug approved by the ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : United States
Sutro Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sutro Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2016
  • by Global Data

Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology, Inc. is a biopharmaceutical company that focuses on the development therapeutics for the treatment of cancer. The company’s ...

  • Industries : Biopharmaceutical
  • Countries : United States
Ventria Bioscience - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ventria Bioscience - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2016
  • by Global Data

Summary Ventria Bioscience (Ventria), a subsidiary of Synergenics LLC is a biopharmaceutical company that develops recombinant medicines and other biotechnology products. The company's expresstec is a ...

  • Industries : Biopharmaceutical
  • Countries : United States
Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kythera Biopharmaceuticals Inc (KYTH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by Global Data

Summary Kythera Biopharmaceuticals Inc (Kythera), a subsidiary of Allergan Plc is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medical aesthetics products. The ...

  • Industries : Biopharmaceutical
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.